• Publications
  • Influence
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective
OBJECTIVE To compare pregnancy rates and the incidence of ovarian hyperstimulation syndrome (OHSS) in donor stimulation cycles where final maturation of oocytes was induced with recombinant hCG orExpand
  • 97
  • 6
Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles.
A retrospective study was conducted in a private infertility centre to evaluate the rate of complications in a large oocyte donation programme. A total of 4052 oocyte retrievals were performedExpand
  • 121
  • 4
Oocyte donation in patients with Turner's syndrome: a successful technique but with an accompanying high risk of hypertensive disorders during pregnancy.
BACKGROUND Few data are available on pregnancy rate and obstetrical outcome after oocyte donation in Turner's syndrome patients. We conducted a retrospective analysis on the outcome of this subgroup.Expand
  • 103
  • 3
Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial
Aim. To compare donor and recipient outcome after inducing the final oocyte maturation with hCG or GnRH agonist in GnRH-antagonist treated oocyte donation (OD) cycles. Methods. Two-hundredExpand
  • 58
  • 3
Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study.
In this prospective, follow-up study of 102 high-risk oocyte donors in their luteal phase, we found a complete absence of ovarian hyperstimulation syndrome (no signs of hemoconcentration or ascites)Expand
  • 40
  • 2
Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial.
BACKGROUND Little information is available on the outcome of controlled ovarian hyperstimulation (COH) using GnRH antagonist in oocyte donation cycles especially in comparison with the short GnRHExpand
  • 33
  • 2
  • PDF
Empty follicle syndrome prevalence and management in oocyte donors.
STUDY QUESTION Is the drug used for final oocyte maturation a factor in determining the prevalence of empty follicle syndrome (EFS)? SUMMARY ANSWER The drug used for final oocyte maturation is notExpand
  • 19
  • 1
Poor outcome in oocyte donation after elective transfer of a single cleavage-stage embryo in Turner syndrome patients.
In this retrospective, matched study we evaluated the outcome of 31 oocyte donation (OD) cycles performed in 29 Turner syndrome (TS) patients involving the elective transfer of a single, freshExpand
  • 14
  • 1
Racial disparity in oocyte donation outcome: a multiethnic, matched cohort study.
BACKGROUND Race and ethnicity are one of the newly investigated patient-related prognostic factors that might affect the outcome of assisted reproduction techniques. To our knowledge no dataExpand
  • 11
  • 1
  • PDF
Learning Curves in 3‐Dimensional Sonographic Follicle Monitoring During Controlled Ovarian Stimulation
Three‐dimensional (3D) sonographically based automated volume calculation (SonoAVC; GE Healthcare, Zipf, Austria) is being introduced in folliculometry during ovarian stimulation; however, clearExpand
  • 20